A study grounded in the hypothesis that PD-L1 expression correlates with activated tumor-infiltrating macrophages and may not be associated with poor prognosis in patients with de novo DLBCL undergoing chemoimmunotherapy is in contrast with findings in solid tumors. Here, CD274 is linked to diffuse large B-cell lymphoma.